• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA LIFESCIENCES CORPORATION DURAGEN; DURA SUBSTITUTE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA LIFESCIENCES CORPORATION DURAGEN; DURA SUBSTITUTE Back to Search Results
Device Problems Improper or Incorrect Procedure or Method (2017); Device Markings/Labelling Problem (2911)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/15/2020
Event Type  malfunction  
Event Description
Duragen regeneration matrix product was not put on the sterile field correctly.Despite labeling with "stop" language, staff understood that the 2nd interior product was not sterile, but did read the smaller message after the "stop" message.Perhaps the written instructions should more clearly lead to how to properly handle the product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURAGEN
Type of Device
DURA SUBSTITUTE
Manufacturer (Section D)
INTEGRA LIFESCIENCES CORPORATION
1100 campus rd
princeton NJ 08540
MDR Report Key10453737
MDR Text Key204377844
Report Number10453737
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 08/11/2020,07/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/26/2020
Is this a Product Problem Report? Yes
Device Operator Other
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA08/11/2020
Date Report to Manufacturer08/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age22630 DA
-
-